KR20030093318A - 환원된 조효소 q 의 안정한 용액 - Google Patents
환원된 조효소 q 의 안정한 용액 Download PDFInfo
- Publication number
- KR20030093318A KR20030093318A KR10-2003-7013495A KR20037013495A KR20030093318A KR 20030093318 A KR20030093318 A KR 20030093318A KR 20037013495 A KR20037013495 A KR 20037013495A KR 20030093318 A KR20030093318 A KR 20030093318A
- Authority
- KR
- South Korea
- Prior art keywords
- solution
- coenzyme
- surfactants
- surfactant
- reduced coenzyme
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/34—Separation; Purification; Stabilisation; Use of additives
- C07C41/46—Use of additives, e.g. for stabilisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
Claims (20)
- 하기 화학식 1 로 나타내는 환원된 조효소 Q 를 함유하는 조효소 Q 용액에 있어서, 환원된 조효소 Q 를 산화에 대해 안정하게 유지하기 위해 조효소 Q 를 리포좀으로 코팅하거나, 계면활성제로 유화 또는 가용화시킨 용액:[화학식 1](식 중, n 은 1 내지 12 의 정수를 나타낸다).
- 제 1 항에 있어서, 환원된 조효소 Q 의 함량이 조효소 Q 의 총량의 20 중량% 이상인 용액.
- 제 1 항에 있어서, 환원된 조효소 Q 의 함량이 조효소 Q 의 총량의 40 중량% 이상인 용액.
- 제 1 항에 있어서, 조효소 Q 의 농도가 0.0001 내지 50 중량% 인 용액.
- 제 1 항에 있어서, 조효소 Q 가 조효소 Q10인 용액.
- 제 1 항 내지 제 5 항 중 어느 한 항에 있어서, 조효소 Q 가 리포좀으로 코팅된 용액.
- 제 6 항에 있어서, 리포좀이 인지질 및/또는 당지질로부터 제조된 용액.
- 제 7 항에 있어서, 인지질이 포스파티딜 콜린, 포스파티딜 에탄올아민, 포스파티딜 세린, 스핑고미엘린, 디세틸 포스페이트, 스테아릴아민, 포스파티딜 글리세롤, 포스파티드산, 포스파티딜 이노시톨 아민, 카르디올리핀, 세라마이드 포스포릴 에탄올아민, 세라마이드 포스포릴 글리세롤 또는 상기 지질의 혼합물인 용액.
- 제 7 항에 있어서, 인지질이 정제 대두 레시틴 또는 난황 레시틴인 용액.
- 제 7 항에 있어서, 당지질이 디갈락토실디글리세리드, 갈락토실디글리세리드 황산 에스테르, 갈락토실세라마이드, 갈락토실세라마이드 황산 에스테르, 락토실세라마이드, 갱글리오시드 G7, 갱글리오시드 G6, 갱글리오시드 G4, 디갈락토실세라마이드 또는 상기 지질의 혼합물인 용액.
- 제 6 항에 있어서, 리포좀막의 성분으로서 스테롤을 추가 함유하는 용액.
- 제 1 항 내지 제 5 항 중 어느 한 항에 있어서, 조효소 Q 가 계면활성제로 유화 또는 가용화되는 용액.
- 제 12 항에 있어서, 계면활성제가 카르복실레이트 음이온성 계면활성제, 술포네이트 음이온성 계면활성제, 술페이트 음이온성 계면활성제, 포스페이트 음이온성 계면활성제, 아민염 양이온성 계면활성제, 4 차 암모늄염 양이온성 계면활성제, 아미노카르복실레이트 양쪽성 (ampholytic) 계면활성제, 카르복시베타인 양성 계면활성제, 술페이트 양성 계면활성제, 술폰산 양성 계면활성제, 에테르 비이온성 계면활성제, 에테르 에스테르 비이온성 계면활성제, 에스테르 비이온성 계면활성제, 블록 중합체 비이온성 계면활성제, 질소 함유 비이온성 계면활성제, 천연 계면활성제, 단백질 가수분해물로부터 유도된 계면활성제, 중합체성 계면활성제, 티탄 및 규소를 함유하는 계면활성제, 및 플루오로카본 계면활성제로 이루어진 군으로부터 선택되는 하나 이상인 용액.
- 제 13 항에 있어서, 계면활성제가 폴리솔베이트 또는 폴리옥시에틸렌 경화 피마자유인 용액.
- 제 13 항에 있어서, 계면활성제의 농도가 1 중량% 미만인 용액.
- 제 13 항에 있어서, 계면활성제의 농도가 1 내지 20 중량% 인 용액.
- 제 1 항 내지 제 16 항 중 어느 한 항에 있어서, 용액이 의약품, 식품, 식품 조성물, 음료수, 비료, 화장품, 동물 사료 또는 항산화제로서 사용되는 용액.
- 제 1 항 내지 제 16 항 중 어느 한 항에 있어서, 용액이 주사제, 체액 대체물, 액상 약물, 점안제, 점비제, 점이제, 경구용제, 피부용제, 두피용제 또는 스톡 용액으로서 사용되는 용액.
- 인지질 및/또는 당지질로부터 제조되는 리포좀으로 환원된 조효소 Q 를 코팅하는 것을 포함하는, 환원된 조효소 Q 의 안정화 방법.
- 제 19 항에 있어서, 인지질이 정제 대두 레시틴인 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001138340 | 2001-05-09 | ||
JPJP-P-2001-00138340 | 2001-05-09 | ||
PCT/JP2002/004516 WO2002090304A1 (fr) | 2001-05-09 | 2002-05-09 | Solution stable de coenzyme q reduite |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020057022537A Division KR100617929B1 (ko) | 2001-05-09 | 2002-05-09 | 환원된 조효소 q 의 안정한 용액 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030093318A true KR20030093318A (ko) | 2003-12-06 |
KR100617928B1 KR100617928B1 (ko) | 2006-08-30 |
Family
ID=18985293
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037013495A KR100617928B1 (ko) | 2001-05-09 | 2002-05-09 | 환원된 조효소 q 의 안정한 용액 |
KR1020057022537A KR100617929B1 (ko) | 2001-05-09 | 2002-05-09 | 환원된 조효소 q 의 안정한 용액 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020057022537A KR100617929B1 (ko) | 2001-05-09 | 2002-05-09 | 환원된 조효소 q 의 안정한 용액 |
Country Status (8)
Country | Link |
---|---|
US (2) | US20040126367A1 (ko) |
EP (1) | EP1386905B1 (ko) |
JP (1) | JP3742602B2 (ko) |
KR (2) | KR100617928B1 (ko) |
CN (1) | CN1263447C (ko) |
AU (1) | AU2002255329B2 (ko) |
CA (1) | CA2442151C (ko) |
WO (1) | WO2002090304A1 (ko) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002092067A1 (fr) * | 2001-05-10 | 2002-11-21 | Kaneka Corporation | Composition pour administration transmucosale contenant une coenzyme q en tant qu'ingredient actif |
TWI329510B (en) | 2001-10-10 | 2010-09-01 | Kaneka Corp | Method of stabilizing reduced coenzyme q10 |
TWI305547B (en) | 2001-12-27 | 2009-01-21 | Kaneka Corp | Processes for producing coenzyme q10 |
TW200302055A (en) | 2002-01-18 | 2003-08-01 | Kaneka Corp | Ubiquinol-enriched fat-containing foods |
TW200302056A (en) * | 2002-01-18 | 2003-08-01 | Kaneka Corp | Method for stabilizing reduced coenzyme Q10 and composition therefor |
TW200304372A (en) * | 2002-03-20 | 2003-10-01 | Kanegafuchi Chemical Ind | Compositions for diabetes |
DE602004023823D1 (de) * | 2003-03-11 | 2009-12-10 | Kaneka Corp | Öl-in-wasser-emulsion, die coenzym q10 enthält, und verfahren zu ihrer herstellung |
US7358402B2 (en) | 2003-09-10 | 2008-04-15 | Kaneka Corporation | Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal |
WO2005033054A1 (ja) * | 2003-09-10 | 2005-04-14 | Kaneka Corporation | 安定性に優れた還元型補酵素q10結晶及び還元型補酵素q10結晶を含有する組成物 |
WO2005035477A1 (ja) * | 2003-10-08 | 2005-04-21 | Kaneka Corporation | キノン骨格を有する化合物の安定化方法及び安定化された組成物 |
TW200524579A (en) * | 2003-11-28 | 2005-08-01 | Kaneka Corp | Composition for protecting liver functions |
CN102258503B (zh) | 2004-01-22 | 2019-08-16 | 迈阿密大学 | 局部辅酶q10制剂及其使用方法 |
WO2005097091A1 (ja) * | 2004-04-09 | 2005-10-20 | Kaneka Corporation | 還元型補酵素q10およびカロチノイド類を含有した組成物 |
CA2578347A1 (en) * | 2004-08-30 | 2006-03-09 | Kaneka Corporation | Mitochondria activators |
AU2004326297B2 (en) | 2004-11-16 | 2008-08-07 | Bioavailability, Inc. | High concentration self-microemulsifying coenzyme Q10 preparations for nutritional use |
KR20070091680A (ko) * | 2004-12-24 | 2007-09-11 | 가부시키가이샤 가네카 | 환원형 보효소 q10을 함유하는 고형 제제 및 그의 제조방법 |
US20060147542A1 (en) * | 2004-12-24 | 2006-07-06 | Tadao Ono | Solid preparation containing reduced coenzyme Q10 and method for producing the same |
JP4877899B2 (ja) * | 2005-01-25 | 2012-02-15 | 学校法人近畿大学 | 薬物徐放出性球状微粒子及びその製造方法 |
US20060198830A1 (en) * | 2005-03-01 | 2006-09-07 | Siddharth Shastri | Ubiquinone composition and a container for its convenient transport and storage |
US20080254016A1 (en) * | 2005-03-29 | 2008-10-16 | Kaneka Corporation | Composition For Increasing Anti-Oxidation Activity In Blood |
KR100710639B1 (ko) | 2005-09-21 | 2007-04-24 | 주식회사 씨티씨바이오 | 코엔자임 q10을 함유한 투명한 액상 제제 및 그의제조방법 |
US8506956B2 (en) * | 2005-10-31 | 2013-08-13 | Kaneka Corporation | Method for stabilizing reduced coenzyme Q10 |
WO2007052802A1 (ja) * | 2005-11-07 | 2007-05-10 | Kaneka Corporation | 酸化に対して安定な還元型補酵素q10含有組成物、及び還元型補酵素q10を安定化する方法 |
CN100525753C (zh) * | 2005-11-15 | 2009-08-12 | 董英杰 | 辅酶q10亚微乳注射液及制备方法 |
JP4960004B2 (ja) * | 2006-04-10 | 2012-06-27 | ポーラ化成工業株式会社 | ベシクル分散剤形のユビデカレノン含有化粧料 |
KR100786884B1 (ko) * | 2006-06-27 | 2007-12-20 | 영진약품공업주식회사 | 코엔자임 q10 함유 수용성 조성물 |
US20080152636A1 (en) * | 2006-09-08 | 2008-06-26 | Kaneka Corporation | Composition containing reduced coenzyme Q10 and lysolecithin |
JPWO2008062559A1 (ja) * | 2006-11-22 | 2010-03-04 | 旭化成ファーマ株式会社 | 栄養補助食品、抗疲労作用剤又は持久力増強剤、機能性食品又は化粧料 |
WO2008101344A1 (en) * | 2007-02-22 | 2008-08-28 | Peter Tomlinson | Soluble bioactive lipophilic compounds compositions |
EP3607937A1 (en) | 2007-03-22 | 2020-02-12 | Berg LLC | Topical formulations having enhanced bioavailability |
US20100179061A1 (en) * | 2007-05-30 | 2010-07-15 | Nisshin Pharma Inc. | Plant growth promoter |
JP6058263B2 (ja) | 2008-04-11 | 2017-01-11 | バーグ リミテッド ライアビリティ カンパニー | 癌細胞においてアポトーシスを誘導する方法および使用 |
US20110020312A1 (en) | 2009-05-11 | 2011-01-27 | Niven Rajin Narain | Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
SG10202010355PA (en) | 2010-03-12 | 2020-11-27 | Berg Llc | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
CN102247301A (zh) * | 2010-05-21 | 2011-11-23 | 上海新都生物科技有限公司 | 还原型辅酶q10的用途及在化妆品中的使用方法 |
KR101708368B1 (ko) | 2010-07-30 | 2017-02-20 | 가부시키가이샤 에리나 | 당대사 개선용 조성물 및 그 조성물을 함유하는 의약 제제 |
CN103608323B (zh) | 2011-04-04 | 2016-08-17 | 博格有限责任公司 | 治疗中枢神经系统肿瘤的方法 |
MX351781B (es) | 2011-06-17 | 2017-10-30 | Berg Llc | Composiciones farmaceuticas inhalables. |
CN102793657B (zh) * | 2012-08-22 | 2015-09-16 | 珀莱雅化妆品股份有限公司 | 一种含生物缓冲剂的护肤品 |
AU2014251045B2 (en) | 2013-04-08 | 2019-06-13 | Berg Llc | Treatment of cancer using coenzyme Q10 combination therapies |
US9757332B2 (en) | 2013-05-20 | 2017-09-12 | Uha Mikakuto Co., Ltd. | Gel-like composition having high ubiquinol content |
SG11201601583TA (en) | 2013-09-04 | 2016-04-28 | Berg Llc | Methods of treatment of cancer by continuous infusion of coenzyme q10 |
RU2605616C1 (ru) * | 2015-11-27 | 2016-12-27 | Закрытое акционерное общество "Институт экспериментальной фармакологии" | Липосомальное средство на основе убихинола и способ его получения |
CN107684561A (zh) * | 2016-08-05 | 2018-02-13 | 上海宣泰生物科技有限公司 | 辅酶q10营养组合物及其应用 |
RU2669374C2 (ru) * | 2016-09-15 | 2018-10-11 | Закрытое акционерное общество "Санкт-Петербургский институт фармации" | Средство на основе биснафтазарина и способ его получения |
DE102019218244A1 (de) * | 2019-11-26 | 2021-05-27 | Beiersdorf Ag | Wirkstoffkombinationen aus Ubichinol und einem oder mehreren Emulgatoren aus der Gruppe der Phosphate und Sulfate sowie kosmetische oder dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend |
WO2023120553A1 (ja) * | 2021-12-24 | 2023-06-29 | 株式会社カネカ | 還元型補酵素q10の保存方法 |
CN115429758B (zh) * | 2022-09-06 | 2024-05-14 | 厦门金达威生物科技有限公司 | 一种辅酶q10-硫辛酸型磷脂纳米复合胶束及其制备方法和应用 |
CN115531319B (zh) * | 2022-11-25 | 2023-05-05 | 仙乐健康科技股份有限公司 | 一种高稳定性脂质体及其制备方法和用途 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5356315A (en) * | 1976-11-01 | 1978-05-22 | Eisai Co Ltd | Emulsified solution of fat soluble drugs |
JPS588010A (ja) * | 1981-07-08 | 1983-01-18 | Eisai Co Ltd | ユビデカレノン含有リポソ−ム |
JPS59161314A (ja) * | 1983-03-06 | 1984-09-12 | Taiho Yakuhin Kogyo Kk | 安定化ユビキノン組成物の製法 |
US4824669A (en) * | 1985-04-11 | 1989-04-25 | Board Of Regents, The University Of Texas System | Formulations of coenzyme Q10 for intravenous use |
US5461037A (en) * | 1985-10-15 | 1995-10-24 | Clintec Nutrition Company | Lipid emulsion |
CH667387A5 (it) * | 1985-12-24 | 1988-10-14 | Seuref Ag | Formulazioni farmaceutiche acquose di ubichinone. |
DK487289D0 (da) * | 1989-10-04 | 1989-10-04 | Novo Nordisk As | Omestring af phospholipider |
IT1250672B (it) * | 1991-07-11 | 1995-04-21 | Idb Holding Spa | Formulazioni orali di ubidecarenone in soluzione acquosa |
JPH06247842A (ja) * | 1993-02-23 | 1994-09-06 | Green Cross Corp:The | リポソーム組成物の製造方法 |
DE69426331T2 (de) * | 1993-08-13 | 2001-06-21 | Seikagaku Kogyo Co Ltd | Arzneimittel gegen nervöse erkrankungen |
JP3889481B2 (ja) * | 1996-08-16 | 2007-03-07 | 株式会社カネカ | 医薬組成物 |
US6045826A (en) * | 1999-04-02 | 2000-04-04 | National Research Council Of Canada | Water-soluble compositions of bioactive lipophilic compounds |
US8753675B1 (en) * | 2000-01-20 | 2014-06-17 | Raj K. Chopra | Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications |
US6740338B1 (en) * | 2000-01-20 | 2004-05-25 | Raj K. Chopra | Reduced form of Cenzyme Q in high bioavailability stable oral dosage form |
CA2406570C (en) * | 2000-05-09 | 2011-07-12 | Kaneka Corporation | Dermal compositions containing coenzyme q as the active ingredient |
GB0017060D0 (en) * | 2000-07-11 | 2000-08-30 | Hunter Fleming Ltd | Production, stabilisation and use of reduced forms of pharmaceutical compounds |
US6441050B1 (en) * | 2000-08-29 | 2002-08-27 | Raj K. Chopra | Palatable oral coenzyme Q liquid |
WO2002092067A1 (fr) * | 2001-05-10 | 2002-11-21 | Kaneka Corporation | Composition pour administration transmucosale contenant une coenzyme q en tant qu'ingredient actif |
JP4603192B2 (ja) * | 2001-05-10 | 2010-12-22 | 株式会社カネカ | 毛髪頭皮用組成物 |
TWI329513B (en) * | 2001-10-12 | 2010-09-01 | Kaneka Corp | Use of reduced coenzyme q for lessening oxidative stress |
TW200302056A (en) * | 2002-01-18 | 2003-08-01 | Kaneka Corp | Method for stabilizing reduced coenzyme Q10 and composition therefor |
US7708990B2 (en) * | 2004-03-23 | 2010-05-04 | Kaneka Corporation | Coenzyme Q compositions persisting in blood |
-
2002
- 2002-05-01 JP JP2002129679A patent/JP3742602B2/ja not_active Expired - Fee Related
- 2002-05-09 EP EP02724742A patent/EP1386905B1/en not_active Expired - Lifetime
- 2002-05-09 KR KR1020037013495A patent/KR100617928B1/ko active IP Right Grant
- 2002-05-09 CA CA2442151A patent/CA2442151C/en not_active Expired - Fee Related
- 2002-05-09 KR KR1020057022537A patent/KR100617929B1/ko active IP Right Grant
- 2002-05-09 AU AU2002255329A patent/AU2002255329B2/en not_active Ceased
- 2002-05-09 WO PCT/JP2002/004516 patent/WO2002090304A1/ja active Application Filing
- 2002-05-09 CN CNB028073045A patent/CN1263447C/zh not_active Expired - Fee Related
- 2002-05-09 US US10/476,083 patent/US20040126367A1/en not_active Abandoned
-
2008
- 2008-12-04 US US12/328,293 patent/US20090087420A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR100617928B1 (ko) | 2006-08-30 |
US20090087420A1 (en) | 2009-04-02 |
WO2002090304A1 (fr) | 2002-11-14 |
JP2003026625A (ja) | 2003-01-29 |
JP3742602B2 (ja) | 2006-02-08 |
US20040126367A1 (en) | 2004-07-01 |
CN1501903A (zh) | 2004-06-02 |
EP1386905B1 (en) | 2012-09-26 |
AU2002255329B2 (en) | 2008-05-08 |
EP1386905A1 (en) | 2004-02-04 |
KR100617929B1 (ko) | 2006-08-30 |
EP1386905A4 (en) | 2005-04-27 |
KR20050116402A (ko) | 2005-12-12 |
CN1263447C (zh) | 2006-07-12 |
CA2442151A1 (en) | 2002-11-14 |
CA2442151C (en) | 2011-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100617928B1 (ko) | 환원된 조효소 q 의 안정한 용액 | |
EP1440962B1 (en) | Stabilized compositions of aqueous reduced coenzyme q solution | |
EP2727580B1 (en) | Astaxanthin-containing composition, method for manufacturing same, and cosmetic | |
EP0100459B1 (en) | An aqueous liquid containing a fat-soluble substance | |
US20110070213A1 (en) | Dermal compositions containing coenzyme q as the active ingredient | |
JPH09510723A (ja) | 皮膚の処置用組成物類 | |
EP1077066A1 (en) | Preventives/remedies for skin diseases | |
EP1339412B1 (en) | Formulation containing phosphate derivatives of electron transfer agents | |
CA2534551C (en) | Cosmetic composition to assist transport of oxygen into the skin | |
EP2308496A2 (en) | Formulation containing phosphate derivatives of electron transfer agents | |
EP4112037A1 (en) | Oxygen gas sustained released nano-emulsion composition and method for producing the same | |
JPH1179930A (ja) | 皮膚用アスコルビン酸誘導体組成物 | |
TWI334862B (ko) | ||
KR20230000400A (ko) | 산소 기체 서방형 나노 에멀젼 조성물 및 이의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120802 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130801 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140808 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150716 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160720 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170719 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180730 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190729 Year of fee payment: 14 |